AGM/EGMApr 30, 2026, 07:07 AM
LXEO Sets 2026 Annual Meeting for June 25; Director Elections & Auditor Ratification
AI Summary
Lexeo Therapeutics, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on Thursday, June 25, 2026, at 10:00 a.m. Eastern. Stockholders will vote on the election of three Class III directors: R. Nolan Townsend, Brenda Cooperstone, and Paula HJ Cholmondeley. Additionally, the agenda includes the ratification of KPMG LLP as the independent registered public accounting firm for fiscal year 2026. The board of directors recommends voting "FOR" both proposals.
Key Highlights
- 2026 Annual Meeting of Stockholders to be held virtually on June 25, 2026, at 10:00 a.m. Eastern.
- Stockholders of record as of May 7, 2026, are entitled to vote at the Annual Meeting.
- Proposals include the election of R. Nolan Townsend, Brenda Cooperstone, and Paula HJ Cholmondeley as Class III directors.
- Proposal also includes the ratification of KPMG LLP as the independent registered public accounting firm for fiscal year 2026.
- Proxy materials will be mailed or made available online to stockholders on or around May 12, 2026.
- Internet or telephone proxies must be received by 11:59 p.m. Eastern on June 24, 2026.
Price Impact
More from LXEO